secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nutex Health Inc. (NUTX)
CIK:        0001479681
Form:       8-K
Filed at:   2023-03-02T23:59:59+00:00
Accession:  0001558370-23-002711
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nutex Health reports FY2022 revenue of $219.3M, net loss of $424.8M on $398.1M goodwill impairment
--------------------------------------------------------------------------------

- Total revenue $219.3M for FY2022; Q4 revenue $53.7M; net loss attributable to Nutex $424.8M.
- Adjusted EBITDA $12.5M for FY2022; Q4 adjusted EBITDA loss of $5.9M.
- Net cash from operating activities $50.6M; cash and equivalents $34.3M at year-end.
- Goodwill impairment of $398.1M; warrant/option valuation revision reduced impairment by $10.3M.
- No Surprises Act reduced revenue by ~$29M in Q3 and $9.6M in H1 2022; company plans 19 new facilities by mid-2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479681/000155837023002711/0001558370-23-002711-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479681/000155837023002711/nutx-20230302x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-002711

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer